These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
531 related items for PubMed ID: 15082203
1. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1). Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Carrasco JC, Requena MJ, Montironi R. Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203 [Abstract] [Full Text] [Related]
2. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena MJ, Montironi R. Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377 [Abstract] [Full Text] [Related]
3. Cyclin D3 expression in primary Ta/T1 bladder cancer. Lopez-Beltran A, Requena MJ, Luque RJ, Alvarez-Kindelan J, Quintero A, Blanca AM, Rodriguez ME, Siendones E, Montironi R. J Pathol; 2006 May; 209(1):106-13. PubMed ID: 16482499 [Abstract] [Full Text] [Related]
4. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E. Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [Abstract] [Full Text] [Related]
5. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK. Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387 [Abstract] [Full Text] [Related]
6. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P. Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671 [Abstract] [Full Text] [Related]
7. Loss of p21Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers. Migaldi M, Sgambato A, Garagnani L, Ardito R, Ferrari P, De Gaetani C, Cittadini A, Trentini GP. Clin Cancer Res; 2000 Aug; 6(8):3131-8. PubMed ID: 10955794 [Abstract] [Full Text] [Related]
8. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy. Zlotta AR, Noel JC, Fayt I, Drowart A, Van Vooren JP, Huygen K, Simon J, Schulman CC. J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686 [Abstract] [Full Text] [Related]
9. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M. Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644 [Abstract] [Full Text] [Related]
10. Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers. Sgambato A, Migaldi M, Faraglia B, Garagnani L, Romano G, De Gaetani C, Ferrari P, Capelli G, Trentini GP, Cittadini A. Cancer Res; 1999 Jul 01; 59(13):3245-50. PubMed ID: 10397272 [Abstract] [Full Text] [Related]
11. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer. Kamai T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI. Br J Cancer; 2001 May 04; 84(9):1242-51. PubMed ID: 11336477 [Abstract] [Full Text] [Related]
12. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Mhawech P, Greloz V, Oppikofer C, Szalay-Quinodoz I, Herrmann F. Cancer; 2004 Jun 01; 100(11):2367-75. PubMed ID: 15160340 [Abstract] [Full Text] [Related]
13. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Korkolopoulou P, Givalos N, Saetta A, Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E, Patsouris E. Hum Pathol; 2005 Aug 01; 36(8):899-907. PubMed ID: 16112007 [Abstract] [Full Text] [Related]
14. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM. Clin Cancer Res; 2004 Aug 01; 10(15):5168-77. PubMed ID: 15297421 [Abstract] [Full Text] [Related]
15. Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features. Møller MB, Nielsen O, Pedersen NT. Am J Clin Pathol; 2001 Mar 01; 115(3):404-12. PubMed ID: 11242797 [Abstract] [Full Text] [Related]
16. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma. Cheng JD, Werness BA, Babb JS, Meropol NJ. Clin Cancer Res; 1999 May 01; 5(5):1057-62. PubMed ID: 10353738 [Abstract] [Full Text] [Related]
17. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct. Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N. Anticancer Res; 2000 May 01; 20(1A):337-44. PubMed ID: 10769677 [Abstract] [Full Text] [Related]
18. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer. Osman I, Scher H, Zhang ZF, Soos TJ, Hamza R, Eissa S, Khaled H, Koff A, Cordon-Cardo C. Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2247-51. PubMed ID: 9815621 [Abstract] [Full Text] [Related]
19. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K, Kosma VM. Br J Cancer; 1999 Aug 01; 80(12):2001-7. PubMed ID: 10471053 [Abstract] [Full Text] [Related]
20. S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications. Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. Oncol Rep; 2003 Aug 01; 10(2):321-5. PubMed ID: 12579266 [Abstract] [Full Text] [Related] Page: [Next] [New Search]